Slight losses on Wall Street put the Dow Jones Industrial Average's record-breaking streak in jeopardy. The blue-chip index has closed at all-time highs for the past ten sessions, its longest streak in three decades. High demand in the housing market boosted new home sales at the beginning of the year. Sales of newly-constructed housing increased by 3.7% percent in January, though that growth was slightly weaker than expected. J.C. Penney (JCP) tumbled after falling short of profit and sales estimates over its fourth quarter. The department store chain also announced plans to close as many as 140 stores over the next few months. Gap (GPS) nudged past fourth-quarter earnings estimates, beating bottom-line forecasts by just a penny. Comparable-store sales increased 2%, in-line with targets.
More from Video
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Breaking down an approach to the long side of this biotech stock.